ROCHE 0245 ROCHE 0245 (Invirase 200 mg)
Generic Name: saquinavir
Pill imprint ROCHE 0245 ROCHE 0245 has been identified as Invirase 200 mg.
Invirase is used in the treatment of nonoccupational exposure; hiv infection and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy. Invirase 200 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for ROCHE 0245 ROCHE 0245
- Generic Name:
- 200 mg
- Green / Yellow
- 22.00 mm
- Prescription only
- Drug Class:
- Protease inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Roche Laboratories
- National Drug Code (NDC):
- Inactive Ingredients:
- lactose anhydrous
sodium starch glycolate type A potato
ferric oxide red
ferric oxide yellow
FD&C Blue No. 2
|NDC Code||Manufacturer / Repackager|
|54868-3699||Physicians Total Care Inc (repackager)|
Note: Inactive ingredients may vary.
More about Invirase (saquinavir)
- Other brands: Fortovase
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.